Mimedx (MDXG) Enterprise Value (2010 - 2026)

Mimedx (MDXG) has 17 years of Enterprise Value data on file, last reported at -$159.8 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 50.12% year-over-year to -$159.8 million; the trailing twelve-month figure through Mar 2026 stood at -$159.8 million (down 50.12% YoY), and the FY2025 full-year result was -$166.1 million, down 59.1% from the prior year.
• Enterprise Value advanced to -$159.8 million in Q1 2026, from -$166.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$48.5 million in Q1 2024 to a low of -$166.1 million in Q4 2025.
• A 5-year average of -$94.0 million and a median of -$78.8 million in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value climbed 24.27% in 2022 and tumbled 119.5% in 2025, its largest moves.
• Tracing MDXG's Enterprise Value over 5 years: stood at -$66.0 million in 2022, then fell by 24.34% to -$82.0 million in 2023, then dropped by 27.34% to -$104.4 million in 2024, then plunged by 59.1% to -$166.1 million in 2025, then gained by 3.82% to -$159.8 million in 2026.
• Business Quant data shows MDXG's Enterprise Value at -$159.8 million in Q1 2026, -$166.1 million in Q4 2025, and -$142.1 million in Q3 2025.